Sensitive ASX Announcement

VivaGel study demonstrates reduced risk of recurrent BV

Published: 03/04/13, 05:17pm (AEST)10 pages
Starpharma Holdings Limited
SPL:ASXHealthcare

Recent SPL Announcements

Price Sensitive only